Renal Function Calculator

Calculate estimated glomerular filtration rate (eGFR) and creatinine clearance. Essential tool for medical professionals.

MDRD Formula
CKD-EPI Formula
Cockcroft-Gault

MDRD Formula: eGFR = 175 × (SCr)-1.154 × (Age)-0.203 × (0.742 if female) × (1.212 if African American)

Where: SCr = Serum Creatinine (mg/dL), Age in years

μmol/L
Normal range: 53-106 μmol/L (0.6-1.2 mg/dL)
Patient age in years
Check if patient is African American (applies to MDRD formula)

CKD-EPI Formula: More accurate than MDRD, especially at higher GFR levels

Uses serum creatinine, age, gender, and race for calculation

μmol/L
Normal range: 53-106 μmol/L (0.6-1.2 mg/dL)
Patient age in years
Check if patient is African American

Cockcroft-Gault Formula: CrCl = [(140 - Age) × Weight × (0.85 if female)] / (72 × SCr)

Where: CrCl = Creatinine Clearance (mL/min), SCr = Serum Creatinine (mg/dL), Weight in kg

μmol/L
Normal range: 53-106 μmol/L (0.6-1.2 mg/dL)
Patient age in years
kg
Patient weight in kilograms
Calculating...

Understanding Renal Function

Renal function refers to the kidney's ability to filter waste products from the blood. The glomerular filtration rate (GFR) is the best overall index of kidney function, representing the volume of fluid filtered from the glomerular capillaries into the Bowman's capsule per unit time.

Key Parameters:

  • eGFR (estimated GFR): Calculated using formulas based on serum creatinine, age, gender, and race
  • Creatinine Clearance (CrCl): Measured or estimated rate at which creatinine is cleared from the blood
  • Serum Creatinine: Waste product from muscle metabolism that is filtered by kidneys

Chronic Kidney Disease (CKD) Staging

Stage eGFR (mL/min/1.73m²) Description Clinical Significance
1 ≥ 90 Normal or high Kidney damage with normal or increased GFR
2 60-89 Mild reduction Kidney damage with mild decrease in GFR
3a 45-59 Mild to moderate reduction Moderate decrease in GFR
3b 30-44 Moderate to severe reduction Moderate decrease in GFR
4 15-29 Severe reduction Severe decrease in GFR
5 < 15 Kidney failure End-stage renal disease (ESRD)

Renal Function Calculation Methods

MDRD (Modification of Diet in Renal Disease) Study Equation

This formula estimates GFR based on serum creatinine, age, gender, and race. It was developed from the MDRD study and is widely used in clinical practice.

Formula: eGFR = 175 × (SCr)-1.154 × (Age)-0.203 × (0.742 if female) × (1.212 if African American)

Where: SCr = Serum Creatinine (mg/dL), Age in years

CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) Equation

This formula is more accurate than the MDRD equation, especially at higher GFR levels. It is currently recommended by many guidelines.

Formula: More complex equation that varies by gender and creatinine level

Generally provides more accurate estimates across the full range of kidney function

Cockcroft-Gault Formula

This formula estimates creatinine clearance (CrCl) based on serum creatinine, age, weight, and gender. It is commonly used for drug dosing adjustments.

Formula: CrCl = [(140 - Age) × Weight × (0.85 if female)] / (72 × SCr)

Where: CrCl = Creatinine Clearance (mL/min), SCr = Serum Creatinine (mg/dL), Weight in kg

Factors Affecting Renal Function

1

Age: GFR naturally declines with age (approximately 1 mL/min/1.73m² per year after age 40)

2

Gender: Men typically have higher muscle mass and creatinine production than women

3

Race/Ethnicity: African Americans tend to have higher muscle mass and creatinine production

4

Body Size: Larger individuals have higher GFR values

5

Muscle Mass: Affects creatinine production and thus GFR estimates

Clinical Applications

  • CKD Diagnosis and Staging: Identifying and classifying chronic kidney disease
  • Drug Dosing: Adjusting medication doses based on renal function
  • Prognosis: Predicting outcomes in various medical conditions
  • Monitoring: Tracking kidney function over time
  • Transplant Evaluation: Assessing donor and recipient kidney function

Clinical Note: These formulas provide estimates of renal function. Actual GFR may vary based on clinical conditions, muscle mass, diet, and other factors. Always interpret results in the context of the patient's overall clinical picture.

Frequently Asked Questions

eGFR (estimated glomerular filtration rate) is a calculated estimate of the actual GFR, standardized to body surface area. Creatinine clearance is an estimate of the rate at which creatinine is cleared from the blood, which approximates GFR. While related, they are calculated differently and may yield slightly different values. eGFR is generally preferred for CKD staging, while creatinine clearance is often used for drug dosing.

The CKD-EPI equation is generally considered more accurate than the MDRD equation, especially at higher GFR levels (>60 mL/min/1.73m²). However, the MDRD equation may be more accurate in patients with advanced kidney disease. The Cockcroft-Gault formula estimates creatinine clearance rather than GFR and is commonly used for drug dosing but may overestimate renal function in certain populations.

Different racial and ethnic groups may have differences in average muscle mass, creatinine production, and other factors that affect serum creatinine levels. The race coefficients in these formulas help account for these differences to provide more accurate estimates of renal function across diverse populations.

The Cockcroft-Gault formula is often preferred for drug dosing adjustments because many medication dosing guidelines were developed using this formula. However, eGFR (particularly using the CKD-EPI equation) is generally preferred for diagnosing and staging chronic kidney disease. Always follow specific institutional or guideline recommendations for your clinical context.

The frequency of renal function monitoring depends on the patient's clinical situation. For healthy adults with no risk factors, annual screening may be sufficient. Patients with risk factors for kidney disease (diabetes, hypertension, family history) should be monitored more frequently, typically every 6-12 months. Patients with established kidney disease may need monitoring every 3-6 months or more frequently depending on the stage and rate of progression.